Helping you make cancer patient care your only priority.

Value-Based Cancer Care Support

Thriving in a value-based care environment requires changes to virtually every area of an oncology practice, including the patient experience. Practices in The US Oncology Network provide a variety of non-medical support services to help patients and their families including survivorship, financial counseling, patient assistance programs and advance care planning.

We provide tools that empower practices to succeed in this transformation. Our expertise and comprehensive solutions have been tested and proven in a value-based care environment – ultimately increasing patient satisfaction with their cancer care experience.


Learn More

Cutting-Edge Cancer Clinical Trials

Our world-renowned clinical research program is one of the largest community-based oncology research programs in the U.S. We enable practices to offer patients access to the latest cancer clinical trial options in their local communities, providing the opportunity for better outcomes while contributing to the advancement of cancer treatment.

  • 88,000 patients enrolled in cancer clinical trials to date
  • Contributed to more than 100 FDA-approved cancer therapies
  • Hundreds of research programs enrolling patients at any given time
  • Accelerated enrollment for cancer clinical trials with highly targeted or rare patient populations

Search Clinical Trials

Upcoming Clinical Trials

Prostate Cancer - USOR: 24310

An Open-Label, Phase 1/1b Study of ORIC-944 as a Single Agent or in Combination with an Androgen Receptor Pathway Inhibitor in Patients with Metastatic Prostate Cancer (ORIC-944-01)

ClinicalTrials.gov ID

NCT05413421

Breast Cancer - USOR: 21462

A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/neu Positive Subjects with Residual Disease or High-Risk PCR after both Neoadjuvant and Postoperative Adjuvant Trastuzumab-based Therapy (FLAMINGO-01) (GLSI-21-01)

ClinicalTrials.gov ID

NCT05232916

Myelomas - USOR: 25138

M25-586: A Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

ClinicalTrials.gov ID

NCT07095452

Myelomas - USOR: 23031

64007957MMY2010/MM165: Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)

ClinicalTrials.gov ID

NCT05972135

Gastric Cancer - USOR: 24285

A phase III multi-center, randomized, open-label study to evaluate the efficacy and safety of [177Lu]Lu-DOTA-TATE in patients newly diagnosed with Grade 1 and Grade 2 (Ki-67 <10%) advanced GEP-NET with high disease burden (NETTER-3) Protocol No.: CAAA601A62301

ClinicalTrials.gov ID

NCT06784752

Hematologic - USOR: 24221

A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of mavorixafor in participants with congenital and acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections (X4P-001-110)

ClinicalTrials.gov ID

NCT06056297

Community of Cancer Patient Care Experts

Good things happen when great minds come together, and that’s why we provide a variety of ways for our physicians to connect. Physicians collaborate with their colleagues through physician committees where they determine new ways to lead and guide The US Oncology Network and to shape the future of value-based cancer care. They also interact with one another digitally through My Workspace where more than 1,400 physicians in The Network share ideas and collaborate on complex cases. Additionally, every year we host network-wide conferences and meetings covering a variety of topics to keep physicians abreast of new developments in cancer patient care.


"I have access to a community of physicians and experts going through similar challenges. I am able to reach out to discuss difficult cases; to strategize and expedite solutions."

Rufus Collea, M.D.
New York Oncology Hematology

Patient Advocacy

The US Oncology Network actively advocates regulatory and legislative solutions on behalf of cancer patients, both on the federal and state level, to improve care and to combat proposals that can negatively impact patients. Our highly skilled political experts are dedicated to making sure the voices and concerns of cancer patients are heard in today’s evolving healthcare landscape.

Medically Integrated Dispensing

The use of oral chemotherapy drugs in cancer treatment is increasing at a rapid pace. We provide a comprehensive physician dispensing solution so you can provide the convenience of in-office dispensing to your patients. We combine robust pharmacy technology, managed care expertise, expert pharmacy and clinical support, and comprehensive drug and supply fulfillment to help your practice deliver a better, more comprehensive care experience to put you in control of the oral treatment process.


Integrated Cancer Patient Care

Providing integrated, seamless care under one roof drives better outcomes and increases patient and physician satisfaction, but building a successful multidisciplinary practice is not an easy task. We have a strong history of success in developing integrated oncology practices utilizing a variety of business models. We are committed to enhancing the opportunities for all physicians in The Network to offer integrated value-based cancer care to their patients.


Innovative Technologies

We offer a full range of integrated technology solutions that enable practices to provide patient-focused value-based care. These user-friendly advanced solutions are designed to reduce physician time spent documenting care, freeing up more time for physicians to do what they do best―provide high-quality cancer patient care.

Patient Portal

Oncology patient portal to help patients more efficiently communicate with their care team, enhancing the patient/provider relationship and enabling patients to take a more active role in their care

Learn More

Electronic Health Record (EHR)

Electronic health record equipped for value-based care delivery, providing physicians with complete and accurate information to thoroughly assess a patient’s condition, diagnose problems sooner, prevent errors and support optimal outcomes

Learn More

Clinical Decision Support

Clinical decision support to help ensure patients are receiving the most effective treatments

Learn More

Analytics Engine

Analytics engine to drive value-based care and identify areas where care can be improved

Learn More

Drug Inventory Management

Drug inventory management to help ensure timely access to life saving drugs for patients

Learn More

Excellence in Cancer Care has a Network

As a national network of multi-specialty industry peers, we are dedicated to bringing innovation to local oncology care. We have the backing and resources to offer practices access to capital for expansion, innovative clinical trials through Sarah Cannon Research Institute, and the purchasing power and best-in-class contracting capabilities of Unity Group Purchasing Organization.

Join Our Network

Learn more about our commitment to enabling better cancer care through an integrated and supportive network that helps local practices maintain their independence and prosper.